Navigation Links
Phase 3 Data Show Bayer's Investigational Compound Regorafenib (BAY 73-4506) Met Primary Endpoint Showing Statistically Significant Improvement in Overall Survival in Patients with Metastatic Colorectal Cancer Refractory to Standard Approved Therapi
Date:1/17/2012

o the submission, review, potential approval of the NDA, development and commercialization of pharmaceutical products. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Reference should be made to Onyx's Annual Report on Form 10-K for the year ended December 31, 2010, filed with the Securities and Exchange Commission under the heading "Risk Factors" and Onyx's Quarterly Reports on Form 10-Q for a more detailed description of such factors. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release. Onyx undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

[i] A. Grothey, et al. Results of a randomized Phase 3 trial (CORRECT) of regorafenib plus best supportive care (BSC) versus placebo plus BSC in patients with mCRC who have progressed after standard therapies [January 17, 2012 ASCO-GI Presscast Presentation]. 2012 Gastrointestinal Cancers Symposium; January 19-21, 2012. San Francisco, CA.

[ii] American Cancer Society. Colorectal Cancer Guide. Available from: http://www.cancer.org/acs/groups/cid/documents/webcontent/003096-pdf.pdf. Accessed on October 14, 2011.

[iii] American Cancer Society. Colorectal Cancer Facts & Figures 2011-2013. Available at: http://www.cancer.org/acs/groups/co
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Niiki Pharma Announces the Completion of Phase I Dose Escalation for First-in-Man Anti-Cancer Agent NKP-1339
2. Sangart Initiates Phase 1b Study of MP4CO in Patients With Sickle Cell Disease
3. Merrimack Pharmaceuticals Initiates Enrollment in Phase 1 Study of MM-151 in Patients with Refractory Advanced Solid Tumors
4. Suneva Medical to Pursue Expanded Indications for Artefill® With Launch of Phase III Acne Scar Study
5. Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO-GI): Phase III Data on Bayers Investigational Compound Regorafenib (BAY 73-4506) in Patients with Metastatic Colorectal Cancer to be Presented as Late Breaking Or
6. Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program
7. Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients
8. Pearl Therapeutics Announces Successful Completion of Phase 2b Safety and Efficacy Studies of COPD Combination, PT003
9. DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial)
10. Pfizer Initiates Phase 1 Clinical Trial for FVIIa Hemophilia Drug Candidate Developed by Catalyst Biosciences
11. ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/twqfk6/global_medical ) ... Devices Packaging Market - By Packaging type, Regions and ... report to their offering. The ... by its end use industry, i.e., Medical devices industry. ... these devices so as to be tamper evident, and ...
(Date:9/3/2015)... 03, 2015 Research ... addition of the "Investigation Report on China,s ... The clinical demand for steroid drug ... and good efficacy especially its extended use in ... recent years. Progesterone, a natural progestogen produced ...
(Date:9/3/2015)... 2015 Research and Markets( ... "Investigation Report on China,s Entecavir Market, 2010-2019" report ... infected with hepatitis B virus (HBV) exceeds 100 million ... million suffering from chronic Hepatitis B. About 0.5 million ... liver cancer caused by chronic Hepatitis B, causing a ...
Breaking Medicine Technology:Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 2Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 3Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 4Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 5Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 6Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 7Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 8China Progesterone Market Investigation Report 2015-2019 2China Entecavir Market Report 2010-2019 2
... FRAMINGHAM, Mass., Oct. 17 StatSure,Diagnostic Systems, ... receipt,of a $500,000 strategic investment from Inverness ... connection with this financing, StatSure and Inverness,signed ... signed an,agreement whereby Inverness acquired an option ...
... Opening in 13 New Sites, BERKELEY HEIGHTS, ... ) announced that the French Health Products,Safety Agency ... 3 trial of Genasense(R) (oblimersen sodium) Injection, its ... authorization,enables the opening of approximately 13 new investigative ...
Cached Medicine Technology:StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations 2StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations 3Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency 2Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency 3
(Date:9/3/2015)... CA (PRWEB) , ... September 03, 2015 , ... ... the real estate investment landscape by connecting accredited and institutional investors to real ... financing products designed to meet demand from both investors and sponsoring real ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... included Intellicure, Inc., in its Annual Inc. 5000 list of fastest-growing private ... that "only a tiny fraction of the nation's companies have demonstrated such remarkably ...
(Date:9/3/2015)... , ... September 03, 2015 , ... Global Vision ... that it will be spotlighting its award-winning print and artwork inspection solutions, ScanProof ... September 16 and 17 at the Olympia London, booth #F33 , Be the first ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions ... eCOA Congress in Lisbon, Portugal, September 22-24, 2015. The esteemed faculty of ...
(Date:9/3/2015)... ... , ... “Love in Tokyo” an independent romantic comedy film by Michael Solton ... and will be released on DVD early next year, by Maverick Entertainment. The film ... and singer/songwriter, and Jason London, lead from “Dazed and Confused.” , “Love in ...
Breaking Medicine News(10 mins):Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 3Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2
... of vitamin B12 deficiency manifest themselves as depression, sleeplessness, ... are taken as signs of mental decline. In elderly ... ,Vegetarians are particularly at risk of developing ... products. They must ensure that they take a supplement. ...
... on several pounds in their freshman year. Freshman 15 is a ... pounds in their freshman year. Though this may be an exaggerated ... first study was conducted on 907 students at a huge public ... and guys gained an average of 7.8 pounds in their freshman ...
... problems and hurting outdoor-related businesses in Singapore is likely ... ,The prolonged pall that has enveloped Southeast Asia ... the northeast monsoon douses the fires raging in Indonesia's ... prediction. ,Experts said intermittent showers are unlikely ...
... School of Medicine in St. Louis have identified yet ... in rats,// the research team found exposure to nicotine ... rotator cuff repair following surgery in human patients. ... problems, from cardiovascular disease to lung disorders. Many of ...
... antiaging supplement has no effect on aging markers such ... and glucose tolerance in elderly men and// women, according ... study appear in the Oct. 19 issue of the ... serve to dispel the belief that dehydroepiandrosterone (DHEA), sold ...
... how a bioactive molecule involved with allergy, inflammation ... according to findings //published online this week in ... ,Mast cells are specialized cells that react ... the body’s allergic response, leading to conditions like ...
Cached Medicine News:Health News:Cigarette Smoking Impedes Tendon-to-Bone Healing 2Health News:Cigarette Smoking Impedes Tendon-to-Bone Healing 3Health News:Popular Antiaging Supplement Has No Beneficial Effects 2Health News:Potential New Therapeutic Target for Asthma, Allergies and Cancer 2
... OB/GYN, ER/Trauma, ICC/CCU, woundcare and burn ... precision and control, plus consistent high ... SATIN PLUS* Sterile Singles deliver all ... provides excellent tactile sensitivity. The gloves ...
... Soft translucent material for ... finger cot with additional ... Full-width 50mm adhesive strip ... finger lift for easy ...
NEAR-SkinTM Incise Drape Aggressive adhesive with no residue High moisture permeability for extended adhesion Low-glare matte finish film Product number identification...
... IV and the Penilab V have an exceptionally sensitive ... is similar to the Model 1061 shown below, but ... added later. The Penilab V has a Doppler. ... accessories you'll need to get started. Latex rubber ...
Medicine Products: